S P Marso

Summary

Affiliation: Saint Luke's Hospital
Country: USA

Publications

  1. ncbi request reprint Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting
    S P Marso
    Department of Cardiology, The Cleveland Clinic Foundation, OH, USA
    Am Heart J 139:939-44. 2000
  2. ncbi request reprint Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease
    Mehdi H Shishehbor
    Department of Internal Medicine, Cardiovascular Imaging Center, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiol 91:1514-7, A9. 2003
  3. ncbi request reprint Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality
    Steven P Marso
    Mid America Heart Institute, Kansas City, Missouri 64111, USA
    Eur Heart J 24:1323-8. 2003
  4. doi request reprint Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial
    Steven P Marso
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri Electronic address
    Am Heart J 166:823-30.e5. 2013
  5. doi request reprint Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Imaging 5:S42-52. 2012
  6. doi request reprint Percutaneous coronary intervention use in the United States: defining measures of appropriateness
    Steven P Marso
    Saint Luke s Mid America Heart Institute and the University of Missouri, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Interv 5:229-35. 2012
  7. ncbi request reprint Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years
    Steven P Marso
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, MO 64111, USA
    Am Heart J 145:270-7. 2003
  8. ncbi request reprint Improving in-hospital mortality in the setting of an increasing risk profile among patients undergoing catheter-based reperfusion for an acute myocardial infarction without cardiogenic shock
    Steven P Marso
    Mid America Heart Institute, St Luke s Hospital, Kansas City, Missouri 64111, USA
    J Invasive Cardiol 15:711-6. 2003
  9. ncbi request reprint Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries
    Steven P Marso
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    Diabetes Care 31:989-94. 2008
  10. ncbi request reprint Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)
    Steven P Marso
    The Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri, USA
    Am J Cardiol 100:206-10. 2007

Collaborators

Detail Information

Publications52

  1. ncbi request reprint Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting
    S P Marso
    Department of Cardiology, The Cleveland Clinic Foundation, OH, USA
    Am Heart J 139:939-44. 2000
    ..We hypothesized that diabetic patients with evidence of proteinuria would have increased mortality and clinical event rates after isolated coronary artery bypass grafting compared with nonproteinuric diabetic patients...
  2. ncbi request reprint Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease
    Mehdi H Shishehbor
    Department of Internal Medicine, Cardiovascular Imaging Center, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiol 91:1514-7, A9. 2003
  3. ncbi request reprint Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality
    Steven P Marso
    Mid America Heart Institute, Kansas City, Missouri 64111, USA
    Eur Heart J 24:1323-8. 2003
    ..We sought to evaluate the risk of long-term mortality with respect to post-operative elevation of the isoenzyme CK-MB following first-time isolated coronary artery bypass grafting (CABG) surgery...
  4. doi request reprint Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial
    Steven P Marso
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri Electronic address
    Am Heart J 166:823-30.e5. 2013
    ..Liraglutide is a human glucagon-like peptide receptor analog approved for use in patients with type 2 diabetes mellitus (T2DM)...
  5. doi request reprint Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Imaging 5:S42-52. 2012
    ..The goal of this study was to characterize the extent and composition of coronary atherosclerosis in patients with diabetes mellitus or the metabolic syndrome (Met Syn) presenting with acute coronary syndromes (ACS)...
  6. doi request reprint Percutaneous coronary intervention use in the United States: defining measures of appropriateness
    Steven P Marso
    Saint Luke s Mid America Heart Institute and the University of Missouri, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Interv 5:229-35. 2012
    ....
  7. ncbi request reprint Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous coronary intervention: an analysis of 25,223 patients over 20 years
    Steven P Marso
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, MO 64111, USA
    Am Heart J 145:270-7. 2003
    ..However, it remains unclear whether patients with diabetes mellitus also have an increased hazard for early death after either elective or urgent PCI...
  8. ncbi request reprint Improving in-hospital mortality in the setting of an increasing risk profile among patients undergoing catheter-based reperfusion for an acute myocardial infarction without cardiogenic shock
    Steven P Marso
    Mid America Heart Institute, St Luke s Hospital, Kansas City, Missouri 64111, USA
    J Invasive Cardiol 15:711-6. 2003
    ..Therefore, we sought to identify significant predictors of in-hospital mortality, to determine the changing profile of patient demographics and to identify the mortality trend over time...
  9. ncbi request reprint Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteries
    Steven P Marso
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    Diabetes Care 31:989-94. 2008
    ..The purpose of this study was to determine whether an association exists between adiponectin and plaque composition in human coronary arteries...
  10. ncbi request reprint Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)
    Steven P Marso
    The Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri, USA
    Am J Cardiol 100:206-10. 2007
    ....
  11. ncbi request reprint Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology
    S P Marso
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    Int J Immunogenet 33:347-54. 2006
    ..039). Lastly, IL-6 increased following PCI even in the absence of myonecrosis as measured by Tn-I elevation. IL-6 levels are also related to the -174G-->C polymorphism, arterial injury, lesion complexity, and insulin resistance...
  12. ncbi request reprint Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population
    Steven P Marso
    Mid America Heart Institute, University of Missouri Kansas City, 64111, USA
    Diabetes Care 29:1931-2. 2006
  13. ncbi request reprint Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention
    Steven P Marso
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri 64111, USA
    Diab Vasc Dis Res 2:31-6. 2005
    ..In this patient population, the metabolic syndrome correlates with a heightened inflammatory response following elective PCI...
  14. ncbi request reprint Peripheral arterial disease in patients with diabetes
    Steven P Marso
    Mid America Heart Institute, University of Missouri Kansas City, Saint Luke s Hospital, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 47:921-9. 2006
    ..This article will review the clinical implications of the consensus statement and highlight the treatment options available in order to help prevent future ischemic events in diabetic individuals with PAD...
  15. ncbi request reprint Diabetes mellitus is associated with plaque classified as thin cap fibroatheroma: an intravascular ultrasound study
    Steven P Marso
    Mid America Heart Institute, Professor of Medicine, University of Missouri Kansas City, 4401 Wornall Road, Kansas City, MO 64111, USA
    Diab Vasc Dis Res 7:14-9. 2010
    ..ID-TCFA was more common in the most diseased 10 mm segment of diabetic than in non-diabetic coronary arteries. Multivariable adjustment demonstrated age and possibly the presence of diabetes to be independent predictors of ID-TCFA...
  16. ncbi request reprint Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators
    S P Marso
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, MO 64111, USA
    Circulation 102:2952-8. 2000
    ..The efficacy of administering eptifibatide to these patients undergoing in-hospital CABG is unknown...
  17. ncbi request reprint Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Rd, Kansas City, MO 64111, USA
    JAMA 303:2156-64. 2010
    ..The association between the use of bleeding avoidance strategies and post-PCI bleeding as a function of a patient's preprocedural risk of bleeding is unknown...
  18. ncbi request reprint Optimizing the diabetic formulary: beyond aspirin and insulin
    Steven P Marso
    Mid America Heart Institute, University of Missouri Kansas City, Saint Luke s Hospital, 64111, USA
    J Am Coll Cardiol 40:652-61. 2002
    ..This review focuses on the current adjunctive pharmacologic treatment regimen that is well suited for patients with type 2 DM...
  19. ncbi request reprint Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry
    Steven P Marso
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    EuroIntervention 5:212-8. 2009
    ..The objective of this study was to determine if an association exists between VH-IVUS measures of coronary atherosclerosis and the Framingham risk score in a prospective, multinational registry...
  20. ncbi request reprint The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics
    S P Marso
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1269-77. 1999
    ..The aims of this study were to compare mortality and clinical events following percutaneous coronary intervention (PCI) between nondiabetics and diabetics with and without proteinuria...
  21. doi request reprint Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology
    Jason B Lindsey
    Mid America Heart Institute, University of Missouri Kansas City, Saint Luke s Hospital, Kansas City, MO 64111, USA
    Circ Cardiovasc Interv 2:543-8. 2009
    ..Although an association between duration of diabetes and increased coronary heart disease risk has been demonstrated, the relationship between TCFA and diabetes duration is unknown...
  22. ncbi request reprint Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])]
    M A Robbins
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Cardiol 84:1350-3, A8. 1999
    ....
  23. ncbi request reprint Diabetes mellitus: biological determinants of atherosclerosis and restenosis
    S P Marso
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Semin Interv Cardiol 4:129-43. 1999
    ..This review will focus in the underlying patho-biology and the current status of therapeutic interventional strategies for patients with diabetes mellitus...
  24. ncbi request reprint Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk
    Mikhail Kosiborod
    Mid America Heart Institute of Saint Luke s Hospital, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 117:1018-27. 2008
    ..Whether metrics that incorporate multiple glucose assessments during acute myocardial infarction hospitalization are better predictors of mortality than admission glucose alone is not well defined...
  25. ncbi request reprint Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery
    Andrew D Frutkin
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri, USA
    Am J Cardiol 101:53-7. 2008
    ..In conclusion, favorable clinical outcomes were achieved for elective PCI at a hospital without onsite cardiac surgery that used strict program requirements...
  26. ncbi request reprint Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome
    David M Safley
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri 64111, USA
    Diab Vasc Dis Res 2:128-35. 2005
    ..This review will concentrate on the historical data associated with acute coronary syndromes in diabetes mellitus, focusing on revascularisation, drug-eluting stents and antiplatelet therapies...
  27. ncbi request reprint Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus
    S H Park
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5066, USA
    Circulation 104:815-9. 2001
    ..The obese Zucker rat model may be an ideal diabetic model to further characterize the diabetic vascular response to injury...
  28. doi request reprint Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Interv 2:1074-82. 2009
    ..Our aim was to examine the prognostic importance of hemorrhagic and ischemic complications after percutaneous coronary intervention (PCI) in unselected patients...
  29. ncbi request reprint A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass
    A Michael Borkon
    Mid America Heart Institute, Kansas City, Missouri, USA
    Ann Thorac Surg 74:1526-30; discussion 1530. 2002
    ..Selection of the optimum mode of coronary revascularization should not only be directed by technical outcomes, but should also consider patients' postprocedural health status, including symptoms, functionality, and quality of life...
  30. ncbi request reprint Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry)
    Andrew D Frutkin
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 2:614-21. 2009
    ..Our purpose was to evaluate percutaneous coronary intervention (PCI) attempt rates in patients with class I indications for coronary artery bypass graft (CABG) surgery after the introduction of drug-eluting stents (DES)...
  31. doi request reprint Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel
    David M Safley
    Division of Cardiology and Biostatistics, Saint Luke s Health System, Mid America Heart Institute, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Interv 1:295-302. 2008
    ..This study compared the survival benefit of opening a chronic total occlusion (CTO) of the left anterior descending (LAD), left circumflex (LCX), or right coronary artery (RCA)...
  32. ncbi request reprint Improving the pharmacological regimen for patients with diabetes mellitus
    Steven P Marso
    University of Missouri Kansas City, Saint Luke s Hospital, Mid America Heart Institute, Kansas City, Missouri, USA
    Rev Cardiovasc Med 5:139-47. 2004
    ..This review focuses on the current adjunctive pharmacologic treatment regimen that is well-suited for these patients...
  33. ncbi request reprint Intracoronary stenting: an overview for the clinician
    S P Marso
    Department of Cardiology, Cleveland Clinic, Ohio 44195, USA
    Cleve Clin J Med 66:434-42. 1999
    ..But it has drawbacks, such as in-stent restenosis, high cost, and lack of long-term follow-up data. This paper discusses current indications and the future role of stenting...
  34. ncbi request reprint Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization
    David M Safley
    Mid America Heart Institute, St Luke s Hospital, Kansas City, MO 64111, USA
    Circulation 115:569-75. 2007
    ..Patients with peripheral arterial disease often undergo peripheral endovascular revascularization (PER) to alleviate symptoms. Despite the growth of PER, little information exists quantifying the health status benefits after the procedure...
  35. doi request reprint Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry
    Sameer K Mehta
    Division of Cardiovascular Research, Mid America Heart Institute, Saint Luke s Hospital, Kansas City, MO 64111, USA
    Circ Cardiovasc Interv 2:222-9. 2009
    ..We identified baseline clinical characteristics associated with bleeding complications after PCI and developed a simplified, clinically useful algorithm to predict patient risk...
  36. ncbi request reprint The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis
    Steven P Marso
    Saint Luke s Hospital Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    Diab Vasc Dis Res 7:119-30. 2010
    ..77-0.97, p=0.015). Although intensification of glucose control did not affect mortality or non-fatal stroke, the risk for non-fatal myocardial infarction was significantly reduced in patients with type 2 diabetes...
  37. ncbi request reprint Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials
    Hussam Abuissa
    Mid America Heart Institute, Cardiovascular Consultants, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 46:821-6. 2005
    ..We sought to investigate the role of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in preventing the new onset of type 2 diabetes mellitus...
  38. ncbi request reprint Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience
    J A Suero
    Mid-America Heart Institute, St. Luke's Hospital, Kansas City, Missouri, USA
    J Am Coll Cardiol 38:409-14. 2001
    ..Success rates have continued to improve without an accompanying increase in MACE rates. A successfully revascularized CTO confers a significant 10-year survival advantage compared with failed revascularization...
  39. ncbi request reprint The impact of bivalirudin on percutaneous coronary intervention-related bleeding
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    EuroIntervention 6:206-13. 2010
    ..We studied the clinical and economic impact of bivalirudin in clinical practice...
  40. ncbi request reprint Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus
    David M Safley
    Division of Cardiology and Biostatistics, Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    Diab Vasc Dis Res 3:45-51. 2006
    ..Angiographic failure is not associated with an increase in MACE rates or mortality as compared to matched non-CTO patients. However, there is not a measurable improvement in survival in this DM-CTO population...
  41. ncbi request reprint Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction
    Roberto A Corpus
    Section of Cardiology, Biostatistics, and Outcomes Research, Mid America Heart Institute, St Luke s Hospital, Kansas City, MO 64111, USA
    Am Heart J 148:493-500. 2004
    ..The optimal percutaneous interventional strategy for dealing with significant non-culprit lesions in patients with multivessel disease (MVD) with acute myocardial infarction (AMI) at presentation remains controversial...
  42. ncbi request reprint Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry)
    Sameer K Mehta
    Department of Cardiology, The Mid America Heart Institute, Kansas City, Missouri, USA
    Am J Cardiol 100:1114-8. 2007
    ..EPD use was independently associated with a lower incidence of no-reflow (OR 0.68, p = 0.032), but not in-hospital mortality (1.0% vs 0.9%, p = NS). In conclusion, in current practice, EPDs are used in <25% of SVG PCI procedures...
  43. ncbi request reprint Suitability of saphenous vein graft lesions for the use of distal embolic protection devices
    Sameer K Mehta
    Mid America Heart Institute, St Luke s Hospital, Kansas City, Missouri 64111, USA
    J Invasive Cardiol 20:568-70. 2008
    ..Given the data supporting the use of EPD use in SVG-PCI, we feel that these findings should motivate interventional operators to establish benchmark standards for employing EPDs to improve the care of patients undergoing SVG-PCI...
  44. doi request reprint Chronic total occlusion angioplasty in the United States
    J Aaron Grantham
    Saint Luke s Health System s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 2:479-86. 2009
    ....
  45. ncbi request reprint Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes
    Monvadi B Srichai
    Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am Heart J 147:84-90. 2004
    ....
  46. ncbi request reprint Vulnerable plaque intervention: State of the art
    John J Young
    Swedish Heart and Vascular Institute, Seattle, Washington 98122, USA
    Catheter Cardiovasc Interv 71:367-74. 2008
    ....
  47. ncbi request reprint Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial
    Marino Labinaz
    University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    Circulation 105:322-7. 2002
    ..90 [95% CI, 0.67 to 1.20]) and in patients without a history of CABG (unadjusted HR, 0.89 [95% CI, 0.80 to 0.99])...
  48. ncbi request reprint Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 90:625-8. 2002
  49. ncbi request reprint Diabetes mellitus and vascular risk: continuing the quest for the elusive keystone
    Steven P Marso
    Diab Vasc Dis Res 2:7-8. 2005
  50. ncbi request reprint The editor's roundtable: intravascular ultrasonic imaging of the coronary arteries
    Vincent E Friedewald
    American Journal of Cardiology, and Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA
    Am J Cardiol 99:943-50; quiz 950. 2007
  51. pmc Central role of RAGE-dependent neointimal expansion in arterial restenosis
    Taichi Sakaguchi
    Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    J Clin Invest 111:959-72. 2003
    ..Taken together, these data highlight key roles for RAGE in modulating smooth muscle cell properties after injury and suggest that RAGE is a logical target for suppression of untoward neointimal expansion consequent to arterial injury...